A month after it dismissed its second case against Google, EveryMD LLC has filed a second case against Twitter, this time asserting a patent not previously seen in litigation (2:15-cv-08836). As in its first case against Twitter, filed in 2013, EveryMD focuses its infringement allegations on the company’s e-mail services. Once again, the NPE accuses Twitter of infringing a patent that generally concerns sending messages through an intermediary that may or may not be online (8,504,631). However, the recently filed case also involves a second patent (9,137,192) that relates to generating webpages for members of a group. While EveryMD has asserted the ‘631 patent in five cases to date, this infringement suit is the first in which the ‘192 patent has been asserted. The ‘192 patent issued in September 2015 to Frank Weyer and Troy Javaher, EveryMD’s principals, who assigned the patent to EveryMD the same day.